MedPath

Study to establish the safety of using antipyretics with febrile seizures and assess whether acetaminophen could reduce the recurrent risk of febrile seizure in the same fever episode.

Not Applicable
Conditions
febrile seizure
Registration Number
JPRN-UMIN000028272
Lead Sponsor
Department of Pediatrics, Hirakata City Hospital 2-14-1 Kinya-honmachi, Hirakata, Osaka 573-1013, Japan Tel: +81-72-847-2821; Fax: +81-72-847-2825
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
500
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients with seizure over 15 minutes were excluded from the study as status epilepticus. 2)Patients with diarrhea were excluded because it is difficult to put suppositories and other pathologies may be involved such as convulsion with mild gastroenteritis . 3)Patients with epilepsy, chromosomal abnormality, inherited metabolic diseases, brain tumor, cerebral hemorrhage, hydrocephalus, and those with a history of intracranial surgery were excluded. 4)Patients who were used to prevent febrile seizuress with diazepam suppository were excluded. 5)Patients take antihistamine that may increase seizure susceptibility in patients with febrile seizures were also excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The outcome is the recurrece of febrile seizure in the same fever episode.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath